Financhill
Back

Beam Therapeutics Stock Predictions

Beam Therapeutics Stock Forecast

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 47.1% based on the past 5 years of stock performance.
  • Beam Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
  • Is Beam Therapeutics Stock Undervalued?
    The current Beam Therapeutics [BEAM] share price is $20.17. The Score for BEAM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • BEAM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Beam Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 47.1% based on the past 5 years of stock performance.

Beam Therapeutics Stock Rating

Buy
56
Beam Therapeutics (BEAM) is a Buy

Is Beam Therapeutics overpriced?

  • Beam Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%

Beam Therapeutics Stock Price History

Is BEAM stock going to rise?

  • The current trend is relatively stagnant and BEAM is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
beamtx.com

52-Week Data

52-Week High:
35.25
52-Week Low:
13.53

Prediction Charts

Market Cap:
1.7B
Price in USD:
20.17
Volume:
1.7M
Beta:
1.90

Technical Analysis

SMA50:
23.23
SMA100:
24.89
SMA200:
25.11
52-Wk Change:
-11.3%

Stock Predictions

  • Is Beam Therapeutics stock public?
    Yes, Beam Therapeutics is a publicly traded company.
  • What is the Beam Therapeutics stock quote today?
    The Beam Therapeutics stock price is 20.17 USD today.
  • How to buy Beam Therapeutics stock online?
    You can buy Beam Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-4 15.83 15.27 16.67 14.72
Apr-7 14.51 15.30 16.04 13.53
Apr-8 16.19 14.54 16.19 13.99
Apr-9 14.17 16.37 17.04 13.54
Apr-10 15.76 14.63 15.82 13.98
Apr-11 14.58 15.47 15.67 14.55
Apr-14 15.99 17.00 17.21 15.75
Apr-15 16.79 17.28 17.94 16.60
Apr-16 16.98 16.62 16.98 16.04
Apr-17 16.58 17.00 17.20 16.49
Apr-21 16.78 18.24 19.48 16.66
Apr-22 18.38 19.13 19.31 18.34
Apr-23 20.00 19.87 20.81 19.85
Apr-24 19.87 20.17 20.20 19.45

Beam Therapeutics Earnings

Beam Therapeutics Earnings Report: Per Share Beam Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Beam Therapeutics Forecast Revenue Growth

Beam Therapeutics Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.02 per share, and an increase next year of $0.05 per share.

* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.